(Q42837851)

8 November 2017

Comment: analyses using time-dependent pioglitazone usage in Cox models may lead to wrong conclusions about its association with cancer (English)

1 reference

8 November 2017

Xilin Yang

1

1 reference

8 November 2017

Juliana C N Chan

series ordinal

2

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 August 2011

1 reference

8 November 2017

1 reference

8 November 2017

34

1 reference

8 November 2017

8

1 reference

8 November 2017

e136; author reply 137

1 reference

Cohort study of pioglitazone and cancer incidence in patients with diabetes

8 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142053

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142053

Diabetes mellitus, fasting glucose, and risk of cause-specific death

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142053

Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3142053

27 May 2018

Identifiers

DOI

10.2337/DC11-0627

1 reference

8 November 2017

1 reference

8 November 2017

PubMed publication ID

21788639

1 reference